Ionis Pharmaceuticals (IONS) Inventory (2017 - 2026)

Ionis Pharmaceuticals' Inventory history runs 10 years deep, the most recent figure standing at $5.6 million for Q1 2026.

• On a quarterly basis, Inventory fell 51.69% year-over-year to $5.6 million in Q1 2026; TTM through Mar 2026 was $5.6 million, a 51.69% decrease from a year earlier, with the FY2025 full-year figure at $10.0 million, down 19.69% from the prior year.
• Inventory slipped to $5.6 million in Q1 2026 per IONS's latest filing, from $10.0 million in the prior quarter.
• Across five years, Inventory topped out at $30.3 million in Q1 2024 and bottomed at $5.6 million in Q1 2026.
• The 5-year median for Inventory is $20.6 million (2022), against an average of $18.4 million.
• Across the five-year window, Inventory soared 68.15% in 2024 and plunged 70.47% in 2025, its largest moves.
• Year by year, Inventory stood at $22.0 million in 2022, then tumbled by 66.23% to $7.4 million in 2023, then surged by 68.15% to $12.5 million in 2024, then decreased by 19.69% to $10.0 million in 2025, then slumped by 44.7% to $5.6 million in 2026.
• Per Business Quant, the three latest IONS Inventory figures stand at $5.6 million (Q1 2026), $10.0 million (Q4 2025), and $10.5 million (Q3 2025).